Products

Clazakizumab (Gly-004CL)

Clazakizumab (formerly ALD518 and BMS-945429) is an aglycosylated, humanized monoclonal antibody against interleukin-6. It is an investigational drug for cancer and rheumatoid arthritis due to its anti-inflammatory properties.
The relatively long half-life of about 30 days should allow less frequent and subcutaneous injections.
It is made using yeast cells rather than the standard Chinese hamster ovary cells.      

Specifications
Type
Humanized Whole antibody
Protein Chemical Formula
C6426H9972N1724O2032S42
Protein Average Weight
145.2 kg/mol
CAS NO.
1236278-28-6
Mechanism of Action
Interleukin 6 inhibitors
References
Alternative Names
BMS-945429; ALD 518; ALD518-003; BMS-645429

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved